Cannara Biotech Inc (LOVE)

Currency in CAD
1.8600
-0.0200(-1.06%)
Real-time Data·
LOVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.85001.8600
52 wk Range
1.55002.0700
Key Statistics
Prev. Close
1.88
Open
1.85
Day's Range
1.85-1.86
52 wk Range
1.55-2.07
Volume
4.31K
Average Volume (3m)
44.04K
1-Year Change
-0.5348%
Book Value / Share
1.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LOVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.3750
Upside
+81.45%
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Cannara Biotech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.3750
(+81.45% Upside)

Earnings

Latest Release
Jul 15, 2026
EPS / Forecast
0.05 / 0.05
Revenue / Forecast
31.29M / 32.23M
EPS Revisions
Last 90 days

LOVE Income Statement

Compare LOVE to Peers and Sector

Metrics to compare
LOVE
Peers
Sector
Relationship
P/E Ratio
17.2x−3.5x11.6x
PEG Ratio
−0.490.010.03
Price/Book
1.5x0.7x1.5x
Price / LTM Sales
1.6x1.4x0.9x
Upside (Analyst Target)
72.9%46.1%23.2%
Fair Value Upside
Unlock18.9%14.0%Unlock

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Employees
452
Market
Canada

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
247.89K0.25%466.04K
Other Institutional Investors
49.41M50.02%92.89M
Public Companies & Retail Investors
49.12M49.73%92.35M
Total
98.78M100.00%185.71M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Javaa Private Equity Inc.25.70%25,383,79047,722
Investissements Olymbec Inc.24.09%23,792,92044,731

People Also Watch

104.24
GIBa
-0.73%
189.83
DOL
+0.22%
35.610
LUN
+3.10%
6.330
BIR
+2.10%
28.97
MFI
-1.19%

FAQ

What Is the Cannara Biotech (LOVE) Stock Price Today?

The Cannara Biotech stock price today is 1.8600 CAD.

What Stock Exchange Does Cannara Biotech Trade On?

Cannara Biotech is listed and trades on the Toronto Stock Exchange.

What Is the Stock Symbol for Cannara Biotech?

The stock symbol for Cannara Biotech is "LOVE."

What Is the Cannara Biotech Market Cap?

As of today, Cannara Biotech market cap is 183.7300M CAD.

What Is Cannara Biotech's Earnings Per Share (TTM)?

The Cannara Biotech EPS (TTM) is 0.1099.

When Is the Next Cannara Biotech Earnings Date?

Cannara Biotech will release its next earnings report on Nov 24, 2026.

From a Technical Analysis Perspective, Is LOVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Cannara Biotech Stock Split?

Cannara Biotech has split 1 times.

How Many Employees Does Cannara Biotech Have?

Cannara Biotech has 452 employees.

What is the current trading status of Cannara Biotech (LOVE)?

As of Jul 30, 2026, Cannara Biotech (LOVE) is trading at a price of 1.8600 CAD, with a previous close of 1.8800 CAD. The stock has fluctuated within a day range of 1.8500 CAD to 1.8600 CAD, while its 52-week range spans from 1.5500 CAD to 2.0700 CAD.

What Is Cannara Biotech (LOVE) Price Target According to Analysts?

The average 12-month price target for Cannara Biotech is 3.3750 CAD, with a high estimate of 4 CAD and a low estimate of 3 CAD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +81.45% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.